Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU, as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck

NCT00255476 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00255476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00255476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU, as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2004
Completion date
July 31, 2007
Enrollment
64
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of head and neck, squamous cell cancer